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Intelligence of individuals with Duchenne muscular dystrophy (DMD) is lower than the general 
population.  Cognitive impairment, epilepsy, autism and attention deficit hyperactivity disorder are 
prevalent.  Mounting evidence links these symptoms to the loss of dystrophin in the brain; yet central 
nervous system involvement in DMD has been largely ignored.  The most predominant dystrophin 
isoform in the brain is the smaller Dp71 isoform expressed in neurons and glia.  Distal DMD mutations 
affecting Dp71 expression are linked to cognitive impairment.  The function(s) of Dp71 and how its 
absence can lead to cognitive and behavioural symptoms are not well understood.  We are modelling 
the loss of Dp71 both endogenously in DMD patient-derived fibroblasts (which, in controls, naturally 
express Dp71) and with siRNA in neuronal and glial cell lines.  Four patient fibroblast cell lines, each 
harbouring a different DMD gene mutation that naturally results in the loss of Dp71 are being studied.  
Accompanying clinical data confirms these patients display cognitive and/or behavioural symptoms, 
which is severe for two individuals.  Our preliminary findings highlight a role for Dp71 in cell migration 
and proliferation; alterations in these processes are associated with psychiatric disorders prevalent in 
DMD such as autism.  We will present would healing and proliferation assay data exploring these 
role(s) and discuss potential molecular mechanisms behind the cognitive and behavioural symptoms 
observed in DMD.  The high risk of neuropsychiatric syndromes in Duchene warrants early intervention 
to achieve the best possible quality of life; our findings have significant potential to inform ongoing 
drug development in this area.   
 
